+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Thiamine Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 195 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082818
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thiamine market is undergoing rapid transformation, shaped by technological advancement, evolving regulatory frameworks, and shifting consumer priorities. As senior leaders evaluate strategic investment and resilient sourcing, this report provides clear, actionable insights critical for competitive positioning.

Market Snapshot: Thiamine Market Growth and Outlook

The thiamine market grew from USD 292.56 million in 2024 to USD 335.36 million in 2025, and is poised to continue expanding at a CAGR of 14.88%, reaching USD 887.64 million by 2032.

Scope & Segmentation

This report provides in-depth coverage of the entire thiamine value chain, focusing on its emergence as both a vital nutrient and an industrial ingredient across global markets. Segmentation spans key applications, forms, sources, distribution channels, end users, and regions.

  • Application: Animal Feed (aquaculture, poultry, ruminant, swine), Dietary Supplements (multivitamins, performance nutrition, single vitamin), Food & Beverages (baked goods, beverages, confectionery, dairy products), Pharmaceuticals (capsules, injectables, oral liquids, tablets)
  • Form: Liquid (emulsion, solution), Powder (granular, microencapsulated, spray dried)
  • Source: Fermentation (bacterial fermentation, yeast fermentation), Synthetic (biosynthesis, chemical synthesis)
  • Distribution Channel: Offline (direct sales, industrial distributors, specialty stores, pharmacies), Online
  • End User: Animal Health (aqua, poultry, ruminant, swine farms), Human Health (clinics, hospitals, online retailers, retail pharmacies)
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
  • Leading Companies: BASF SE, Koninklijke DSM N.V., Evonik Industries AG, Adisseo France SAS, Xiamen Kingdomway Group Co., Ltd., Zhejiang Medicine Co., Ltd., Zhejiang NHU Co., Ltd., Jiangsu Synco Pharmaceutical & Biological Products Co., Ltd., Novus International, Inc., Cargill, Incorporated

Key Takeaways for Senior Decision-Makers

  • Regulatory authorities globally are redefining thiamine standards, compelling producers to advance formulations and align with fortification and labeling requirements.
  • Technological innovation in fermentation and microencapsulation is lowering production costs and improving ingredient stability across product categories.
  • Supply chain transparency and traceability, driven by digitalization, are increasingly critical for compliance and consumer trust, especially in sectors demanding ethical sourcing.
  • Strategic alliances between ingredient manufacturers and brand owners are expediting co-development of thiamine formulations tailored for specific market needs, such as animal feed and personalized wellness.
  • Regional differences in regulation, infrastructure, and consumer preferences underscore the need for localized market entry and bespoke compliance strategies.

Assessing Tariff Impact on Supply Chains

The introduction of new tariff regimes in the United States is reshaping global thiamine sourcing strategies. In response to cost adjustments, companies are accelerating domestic production investments and diversifying supplier portfolios. Collaborative measures between regulatory and supply chain teams are also mitigating compliance risks and stabilizing import-export flows.

Advances in Technology and Application

Recent advances in fermentation and microencapsulation are enabling manufacturers to optimize bioavailability, stability, and application versatility of thiamine. These technologies are widely adopted across animal feed, dietary supplements, and processed foods, reflecting strong demand for premium and functional nutrient delivery solutions.

Methodology & Data Sources

This study integrates primary research—through interviews with stakeholders such as suppliers, manufacturers, and end users—with secondary analysis of academic and trade resources. Insights were verified using data triangulation, expert validation sessions, and scenario planning, ensuring robust, actionable conclusions.

Why This Report Matters

  • Enables confident decision-making by delivering an integrated view of supply chains, technology shifts, and regulatory changes impacting the thiamine market.
  • Equips organizations to anticipate risks, leverage innovation, and adapt business models for sustainable growth and resilience.
  • Helps align corporate strategies with region-specific trends, supporting targeted investment and partnership opportunities in high-growth segments.

Conclusion

As the thiamine market evolves, proactive leadership and focused innovation are foundational to market success. This comprehensive intelligence supports leaders seeking to strengthen supply resilience, optimize operations, and capture new growth opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising consumer demand for energy-boosting thiamine-enriched beverages in sports nutrition
5.2. Innovative microencapsulation techniques enhancing thiamine stability and bioavailability in supplements
5.3. Surge in plant-based food fortification with thiamine to address vegan nutritional gaps
5.4. Regulatory shifts mandating thiamine fortification in staple foods across emerging markets
5.5. Increased research into thiamine derivatives for neuroprotective therapies in aging populations
5.6. Expansion of lipid-soluble thiamine prodrugs targeting improved central nervous system delivery
5.7. Growing investment in sustainable fermentation processes for cost-effective thiamine production
5.8. Development of functional cereal products enriched with thiamine to combat childhood malnutrition
5.9. Adoption of rapid analytical methods for real-time thiamine quantification in food manufacturing
5.10. Strategic partnerships between ingredient suppliers and pharmaceutical firms for thiamine-based formulations
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Thiamine Market, by Application
8.1. Animal Feed
8.1.1. Aquaculture
8.1.2. Poultry
8.1.3. Ruminant
8.1.4. Swine
8.2. Dietary Supplements
8.2.1. Multivitamins
8.2.2. Performance Nutrition
8.2.3. Single Vitamin
8.3. Food & Beverages
8.3.1. Baked Goods
8.3.2. Beverages
8.3.3. Confectionery
8.3.4. Dairy Products
8.4. Pharmaceuticals
8.4.1. Capsules
8.4.2. Injectables
8.4.3. Oral Liquids
8.4.4. Tablets
9. Thiamine Market, by Form
9.1. Liquid
9.1.1. Emulsion
9.1.2. Solution
9.2. Powder
9.2.1. Granular
9.2.2. Microencapsulated
9.2.3. Spray Dried
10. Thiamine Market, by Source
10.1. Fermentation
10.1.1. Bacterial Fermentation
10.1.2. Yeast Fermentation
10.2. Synthetic
10.2.1. Biosynthesis
10.2.2. Chemical Synthesis
11. Thiamine Market, by Distribution Channel
11.1. Offline
11.1.1. Direct Sales
11.1.2. Distributors
11.1.2.1. Industrial Distributors
11.1.2.2. Specialty Stores
11.1.3. Pharmacies
11.2. Online
12. Thiamine Market, by End User
12.1. Animal Health
12.1.1. Aqua Farms
12.1.2. Poultry Farms
12.1.3. Ruminant Farms
12.1.4. Swine Farms
12.2. Human Health
12.2.1. Clinics
12.2.2. Hospitals
12.2.3. Online Retailers
12.2.4. Retail Pharmacies
13. Thiamine Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Thiamine Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Thiamine Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. BASF SE
16.3.2. Koninklijke DSM N.V.
16.3.3. Evonik Industries AG
16.3.4. Adisseo France SAS
16.3.5. Xiamen Kingdomway Group Co., Ltd.
16.3.6. Zhejiang Medicine Co., Ltd.
16.3.7. Zhejiang NHU Co., Ltd.
16.3.8. Jiangsu Synco Pharmaceutical & Biological Products Co., Ltd.
16.3.9. Novus International, Inc.
16.3.10. Cargill, Incorporated
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Thiamine market report include:
  • BASF SE
  • Koninklijke DSM N.V.
  • Evonik Industries AG
  • Adisseo France SAS
  • Xiamen Kingdomway Group Co., Ltd.
  • Zhejiang Medicine Co., Ltd.
  • Zhejiang NHU Co., Ltd.
  • Jiangsu Synco Pharmaceutical & Biological Products Co., Ltd.
  • Novus International, Inc.
  • Cargill, Incorporated

Table Information